在性结肠炎中JAK1抑制剂的细胞特异性作用
Suzanne H C Veltkamp1, Philip W Voorneveld1
1Department of Gastroenterology and Hepatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Journal of clinical medicine
|January 25, 2025
概括
简氏激酶1 (JAK1) 抑制剂提供了新的性结肠炎 (UC) 治疗方法,但可变的反应突显了UC异质性. 了解JAK1抑制剂对免疫,上皮和脑膜细胞的影响,是个性化医学的关键.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 简氏激酶1 (JAK1) 抑制剂是治疗性结肠炎 (UC) 的新兴疗法.
- 这些药物向细胞因子介导的炎症通路,在UC病变发生过程中至关重要.
- 然而,患者反应的变化和持续的炎症表明需要更深入的机制理解.
研究的目的:
- 探索JAK1抑制剂在性结肠炎中对免疫,上皮和脑膜细胞的差异效应.
- 调查细胞异质性导致治疗反应变化的原因.
- 确定改善治疗精度和预测患者结果的策略.
主要方法:
- 本综述综合了关于性结肠炎中JAK1抑制的当前文献.
- 它检查了免疫细胞,上皮细胞和树皮细胞对JAK1抑制剂的反应中的作用.
- 讨论了潜在的预测生物标志物和补充治疗点.
主要成果:
- JAK1抑制剂调节关键的炎症通路,但它们对非免疫细胞的影响尚未完全阐明.
- 在UC病变发生过程中的异质性涉及免疫,上皮和体的不同贡献.
- 治疗反应的变化可能源于这些细胞类型与药物作用之间的复杂相互作用.
结论:
- 优化JAK1抑制剂治疗性结肠炎需要了解其对不同细胞类型的影响.
- 预测患者的反应和确定协同治疗对于改善临床结果至关重要.
- 进一步研究JAK1抑制在上皮细胞和树皮细胞中的机制是有必要的.
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Inflammatory Bowel Disease I: Ulcerative Colitis
131
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
131


